Diagnostic Clues for Congenital Cytomegalovirus Infection: Association with Newborn Hearing Screening Tests

다국어 초록 (Multilingual Abstract)

Purpose: To investigate clinical markers for the diagnosis of congenital cytomegalovirus (CMV) infection and determine the correlation between abnormal newborn hearing screening results and asymptomatic congenital CMV infection.
Methods: Medical records of newborns with congenital CMV infection, born at Cheil General Hospital & Women's Healthcare Center from July 2008 to June 2018, were retrospectively reviewed. Infants with congenital CMV infection were classified into “symptomatic,” “asymptomatic,” and “asymptomatic with isolated abnormal automated auditory brainstem response (AABR)” groups. Clinical data were analyzed based on this classification.
Results: Among the 59,424 live births, congenital CMV infection was found in 25 neonates, including 19 symptomatic (0.03%) infants, two asymptomatic, and four asymptomatic with isolated abnormal AABR. Diagnostic clues for the identification of congenital CMV infection were intrauterine growth restriction (IUGR), including microcephaly in 10 infants (40.0%), abnormal AABR in four (16.0%), initial complicated signs in four (16.0%), and abnormal findings on brain ultrasonography in three (12.0%). Other less common markers included petechiae, abnormal findings on antenatal ultrasonography, and co-twin with CMV infection. During the recent 10 years, 53,094 of 59,424 newborns (89.3%) had AABR for hearing screening and 493 (0.9%) did not pass. Among them, 477 (96.8%) were screened for CMV, and results were positive for seven (1.5%). Among the seven infants, four had asymptomatic congenital CMV infection. Overall, 0.8% of the newborns with abnormal AABR (four of 477 infants) were diagnosed as having asymptomatic congenital CMV infection.
Conclusion: The incidence of symptomatic congenital CMV infection was 0.03%, and 0.8% of infants who failed in the newborn hearing screening tests had asymptomatic congenital CMV infection. The most common clinical marker to diagnose congenital CMV infection was IUGR, including microcephaly, and the second isolated marker was abnormal AABR.

참고문헌 (Reference)

1 김지희, "단일 기관에서 경험한 선천성 거대세포바이러스 감염 환자의 임상 양상 및 신경발달학적 추적 관찰" 대한신생아학회 20 (20): 214-220, 2013

2 Medoro A, "“Targeted” screening for cytomegalovirus (CMV)-related hearing loss: it’s time for universal CMV screening in the NICU!" 4 (4): S691-, 2017

3 Cannon MJ, "Universal newborn screening for congenital CMV infection: what is the evidence of potential benefit?" 24 : 291-307, 2014

4 Manicklal S, "The "silent" global burden of congenital cytomegalovirus" 26 : 86-102, 2013

5 서소연, "Serologic Screening of Pregnant Korean Women for Primary Human Cytomegalovirus Infection Using IgG Avidity Test" 대한진단검사의학회 29 (29): 557-562, 2009

6 Grosse SD, "Screening for congenital cytomegalovirus after newborn hearing screening: what comes next?" 139 : e20163837-, 2017

7 Boppana SB, "Saliva polymerase-chain-reaction assay for cytomegalovirus screening in newborns" 364 : 2111-2118, 2011

8 Cannon MJ, "Review of cytomegalovirus seroprevalence and demographic characteristics associated with infection" 20 : 202-213, 2010

9 Kenneson A, "Review and meta-analysis of the epidemiology of congenital cytomegalovirus (CMV) infection" 17 : 253-276, 2007

10 Diener ML, "Outcomes from a hearing-targeted cytomegalovirus screening program" 139 : 2017

11 Stehel EK, "Newborn hearing screening and detection of congenital cytomegalovirus infection" 121 : 970-975, 2008

12 Rawlinson WD, "Neonates with congenital cytomegalovirus and hearing loss identified via the universal newborn hearing screening program" 102 : 110-115, 2018

13 Britt WJ, "Nelson textbook of pediatrics" Elsevier Saunders 1590-1594, 2015

14 Goderis J, "Hearing loss and congenital CMV infection: a systematic review" 134 : 972-982, 2014

15 Ronchi A, "Encouraging postnatal cytomegalovirus (CMV) screening: the time is NOW for universal screening!" 15 : 417-419, 2017

16 Boppana SB, "Dried blood spot real-time polymerase chain reaction assays to screen newborns for congenital cytomegalovirus infection" 303 : 1375-1382, 2010

17 Lee YA, "Diagnosis of cytomegalovirus infection in neonatal and infantile periods using polymerase chain reaction" 39 : 1271-1279, 1996

18 Kim DW, "Cytomegalovirus infection in children: the significance of CMV specific IgM antibody test and virus isolation in the urine" 35 : 890-901, 1992

19 Gantt S, "Cost-effectiveness of universal and targeted newborn screening for congenital cytomegalovirus infection" 170 : 1173-1180, 2016

20 Lim Y, "Congenital cytomegalovirus: who, when, whatwith and why to treat?" 74 (74): S89-S94, 2017

21 Luck SE, "Congenital cytomegalovirus: a European expert consensus statement on diagnosis and management" 36 : 1205-1213, 2017

22 Sohn YM, "Congenital cytomegalovirus infection: incidence and clinical outcome" 34 : 1365-1372, 1991

23 van Zuylen WJ, "Congenital cytomegalovirus infection: clinical presentation, epidemiology, diagnosis and prevention" 7 : 140-146, 2014

24 Fowler KB, "Congenital cytomegalovirus infection" 42 : 149-154, 2018

25 Kim JH, "Congenital asymptomatic cytomegalovirus infection: a comparison of specific IgM antibody test and pp65 antigenemia assay" 41 : 163-169, 1998

26 김천수, "Congenital and perinatal cytomegalovirus infection" 대한소아청소년과학회 53 (53): 14-20, 2010

27 Paik SH, "Clinical features of congenital cytomegalovirus infection in neonates" 13 : 413-419, 2002

28 박경원, "Clinical Significance of Neonatal Lenticulostriate Vasculopathy: Association with Congenital Cytomegalovirus Infection" 대한신생아학회 24 (24): 171-177, 2017